18 July 2011
Responding to the Department of Health’s response to the Value Based Pricing consultation, Mike Hobday, Head of Policy of Macmillan Cancer Support, says:
“We’re pleased that the Government is introducing Value Based Pricing. This new system presents an exciting opportunity to end the inequality in access to cancer drugs that currently exists across the country.
“For too long patients with less common cancers have lost out on receiving the vital medicines they need on the NHS. It is critical that Value Based Pricing results in more people with rarer cancers getting hold of the drugs their doctor recommends to them.
“We look forward to continuing to work with the Government and the Department of Health to improve all cancer patients’ access to effective and innovative drugs.”
For more information and support call Macmillan free on 0808 808 00 00 or visit please visit www.macmillan.org.uk/cancerdrugs.
For further information, please contact:
Julie Wills, Assistant Media & PR Officer, Macmillan Cancer Support
020 7840 4933 (out of hours 07801 307068)
Notes to Editors:
The full text of the Government’s response, along with further information on the consultation, is available on the following website http://www.dh.gov.uk/en/Consultations/Responsestoconsultations/DH_128226.
About Macmillan Cancer Support
Macmillan Cancer Support improves the lives of people affected by cancer, providing practical, medical, emotional and financial support. Working alongside people affected by cancer, Macmillan works to improve cancer care. One in three of us will get cancer. Two million of us are living with it. If you are affected by cancer Macmillan can help.
For more information about Macmillan Cancer Support, visit www.macmillan.org.uk or freephone 0800 500 800 for an information pack.